Canada, Ontario government plan to lower generic drug prices

9 June 2010

The government of Canada's Ontario Province has announced this week that it is lowering generic drug prices and making improvements to the province's drug system to benefit all Ontarians.

The Ministry of Health and Long-Term Care says these improvements include:

' Lowering the price of most generic drugs by at least 50%.
' Eliminating so-called 'professional allowances' - payments generic drug companies make to pharmacy owners in exchange for stocking their products.
' Supporting access to pharmacy services in rural communities by increasing the dispensing fees paid to rural pharmacies by as much as C$5 ($4.76) per prescription filled.
' Expanding the MedsCheck program to assist people with diabetes, long-term care home residents and people who have difficulty travelling to their local pharmacy.
' Creating a transition fund to assist pharmacies in adapting to the fairer drug system.

The changes, which are part of the government's Open Ontario plan, will begin to take effect on July 1, 2010.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Generics